The World Health Organization (WHO) Classification of CNS tumors, specifically CNS5, has even directly incorporated genetic modifiers, such as IDH mutations and 1p/19q codeletion, into the nomenclature of gliomas, highlighting their crucial role in the diagnosis and classification of these tumors (Louis et al., 2021). Here, IDH1 is linked to glioma.